S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC MYELOID LEUKEMIA

Authors: F. Pane, F. Castagnetti, L. Luciano, A. Russo Rossi, E. Abruzzese, R. Bassan, G. Binotto, G. Caocci, G. Cimino, P. Fazi, A. Gozzini, M. Lunghi, R. Marasca, B. Martino, M. Bonifacio, F. Cavazzini, F. Paoloni, G. Saglio, S. Sica, A. Tafuri, D. Vallisa, M. Vignetti, P. Westerweel, G. Rosti, M. Breccia

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000843516.08806.86

Source: Full article

---

Abstract

No abstract found.